neurizon ApS: Financial statements 2025
CVR: 36889845
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
neurizon ApS (CVR 36889845) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 4,175 and a net result of DKK 1,642 compared with DKK -585 the year before. That is an increase of 133.6% compared with the year before. Equity in the 2025 report amounted to DKK 92,461. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 4,175
- Profit/Loss
- DKK 1,642
- Equity
- DKK 92,461
- Total Assets
- DKK 92,461
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 0 | 4 t. | 2 t. | 92 t. | - |
| 2024 | 0 | 2 t. | -585 | 91 t. | - |
| 2023 | 0 | -1 t. | 2 t. | 93 t. | - |
| 2022 | - | 7 t. | 2 t. | 97 t. | - |
| 2021 | - | -32 t. | -32 t. | 124 t. | - |
Official annual report
How creditworthy is neurizon ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
Neurizon ApS has published its annual report for 2024. Revenue came to DKK 0, and the net result was DKK -585.
About neurizon ApS
neurizon ApS is a Danish company of the type Anpartsselskab based in Egå, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Kaare Stenhøj Meier. The board consists of Jens Christian Hedemann Sørensen (chair), Kaare Stenhøj Meier, Mattias karl Johan Valdemar Rasmusson and Morten Flink. The company's owners include ITMEDICO HOLDING ApS, KYNOS ApS and Neurologic Holding ApS. In 2025, the company reported a gross profit of DKK 4,175 and a net result of DKK 1,642 compared with DKK -585 the year before. Equity in the 2025 report amounted to DKK 92,461.